Bobby Yerramilli-Rao

Bobby Yerramilli-Rao is the Chief Strategy Officer and Corporate Vice President, Corporate Strategy at Microsoft, joining the company effective January 2020. Yerramilli-Rao is the co-founder and co-chair of Cambridge Epigenetix, a biosciences company, as well as co-founder of Inflex, a stealth-mode company working on applying biochemistry to cancer treatment. He also was the co-founder and managing partner of Fusion Global Capital, formerly Hermes Growth Partners (HGP), according to his LinkedIn profile.